Goc; Anna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goc; Anna.The latest application filed is for "method of simultaneously treating viral disease caused coronavirus, its variants and mutants using a pharmaceutical micronutrient composition".

Company Profile

7.16.11

Goc; Anna - Sanjose CA
Goc; Anna - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of simultaneously treating viral disease caused coronavirus, its variants and mutants using a pharmaceutical micronutrient composition App 20220304976 - Niedzwiecki; Aleksandra ; et al.	2022-09-29
Micronutrient and plant extract composition and method of improving bone health Grant 11,452,710 - Niedzwiecki , et al. September 27, 2	2022-09-27
Pharmaceutical micronutrient composition and its use to simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants and mutants Grant 11,419,847 - Niedzwiecki , et al. August 23, 2	2022-08-23
Pharmaceutical composition Mix A to treat health conditions associated with elevated glucose levels Grant 11,351,148 - Chatterjee , et al. June 7, 2	2022-06-07
Pharmaceutical composition Mix B to treat health conditions associated with elevated glucose levels Grant 11,337,959 - Chatterjee , et al. May 24, 2	2022-05-24
Pharmaceutical micronutrient composition for simultaneously treating nervous system function, cognitive ability and response to stressors Grant 11,304,922 - Niedzwiecki , et al. April 19, 2	2022-04-19
Pharmaceutical micronutrient composition and its use to simultaneously treat nervous system function, cognitive ability and response to stressors Grant 11,304,921 - Niedzwiecki , et al. April 19, 2	2022-04-19
Micronutrient combination to inhibit coronavirus cell infection App 20220047545 - Niedzwiecki; Aleksandra ; et al.	2022-02-17
Pharmaceutical composition to treat health conditions associated with elevated glucose levels Grant 11,246,855 - Chatterjee , et al. February 15, 2	2022-02-15
Pharmaceutical micronutrient composition and its use to simultaneously improve nervous system function, cognitive ability and response to stressors Grant 11,234,952 - Niedzwiecki , et al. February 1, 2	2022-02-01
Pharmaceutical Composition to treat health conditions associated with elevated glucose levels App 20220023256 - Chatterjee; Madhurima ; et al.	2022-01-27
Pharmaceutical micronutrient composition and its use to simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants and mutants App 20210315857 - Niedzwiecki; Aleksandra ; et al.	2021-10-14
Pharmaceutical Composition And Its Use To Inhibit Membrane Ace2 Expression App 20210315858 - Niedzwiecki; Aleksandra ; et al.	2021-10-14
Pharmaceutical composition and its use to inhibit membrane ACE2 expression Grant 11,135,196 - Niedzwiecki , et al. October 5, 2	2021-10-05
Composition for eye health Grant 10,716,767 - Niedzwiecki , et al.	2020-07-21
Antibacterial and antifungal dental health formulation Grant 10,610,474 - Sumera , et al.	2020-04-07
Composition and its use for increasing innate immune health Grant 10,568,866 - Niedzwiecki , et al. Feb	2020-02-25
Antiplaque and dental health oral formulation Grant 10,463,590 - Sumera , et al. No	2019-11-05
Composition For Eye Health App 20190209489 - Niedzwiecki; Aleksandra ; et al.	2019-07-11
Composition and method of using the same Grant 10,238,619 - Rath , et al.	2019-03-26
Novel Composition Method Of Using The Same For The Treatment Of Lyme Disease App 20160339057 - RATH; MATTHIAS W. ; et al.	2016-11-24
Novel Composition Method Of Using The Same For The Treatment Of Lyme Disease App 20160106777 - Rath; Matthias W. ; et al.	2016-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.